公开(公告)号：WO2008133753A3

公开(公告)日：2008-12-24

申请号：PCT/US2007088027

申请日：2007-12-19

Applicant: ABBOTT LAB ,  BETEBENNER DAVID A ,  MARING CLARENCE J ,  ROCKWAY TODD W ,  COOPER CURT S ,  ANDERSON DAVID D ,  WAGNER ROLF ,  ZHANG RONG ,  MOLLA AKHTERUZZAMAN ,  MO HONGMEI ,  PILOT-MATIAS TAMI J ,  MASSE SHERIE VL ,  CARRICK ROBERT J ,  HE WENPING ,  LU LIANGJUN

Inventor： BETEBENNER DAVID A ,  MARING CLARENCE J ,  ROCKWAY TODD W ,  COOPER CURT S ,  ANDERSON DAVID D ,  WAGNER ROLF ,  ZHANG RONG ,  MOLLA AKHTERUZZAMAN ,  MO HONGMEI ,  PILOT-MATIAS TAMI J ,  MASSE SHERIE VL ,  CARRICK ROBERT J ,  HE WENPING ,  LU LIANGJUN

IPC: A01N43/42 ,  A61K31/44

CPC classification number: C07D471/04 ,  C07D239/94 ,  C07D487/04 ,  C07D487/14 ,  C07D519/00

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ( HCV ) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, coformulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract translation: 公开了有效抑制丙型肝炎病毒（HCV）或其他病毒复制的化合物。 本发明还涉及包含此类化合物的组合物，这类化合物与其它抗病毒剂或治疗剂的共配制或共同施用，用于合成这些化合物的方法和中间体，以及使用此类化合物治疗HCV或 其他病毒感染。

公开(公告)号：EP2094276A4

公开(公告)日：2011-01-05

申请号：EP07874373

申请日：2007-12-19

Applicant: ABBOTT LAB

Inventor： BETEBENNER DAVID A ,  MARING CLARENCE J ,  ROCKWAY TODD W ,  COOPER CURT S ,  ANDERSON DAVID D ,  WAGNER ROLF ,  ZHANG RONG ,  MOLLA AKHTERUZZAMAN ,  MO HONGMEI ,  PILOT-MATIAS TAMI J ,  MASSE SHERIE VL ,  CARRICK ROBERT J ,  HE WENPING ,  LU LIANGJUN

IPC: A61K31/675 ,  C07D487/14

CPC classification number: C07D471/04 ,  C07D239/94 ,  C07D487/04 ,  C07D487/14 ,  C07D519/00

公开(公告)号：CA2672737A1

公开(公告)日：2008-11-06

申请号：CA2672737

申请日：2007-12-19

Applicant: ABBOTT LAB

Inventor： ANDERSON DAVID D ,  WAGNER ROLF ,  CARRICK ROBERT J ,  ZHANG RONG ,  HE WENPING ,  ROCKWAY TODD W ,  MARING CLARENCE J ,  PILOT-MATIAS TAMI J ,  MASSE SHERIE V L ,  COOPER CURT S ,  BETEBENNER DAVID A ,  MO HONGMEI ,  MOLLA AKHTERUZZAMAN ,  LU LIANGJUN

IPC: A01N43/42 ,  A61K31/44

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ( HCV ) or other viruses are disclosed. This invention is also directed to composi tions comprising such compounds, coformulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and interme diates for the syntheses of such compounds, and methods of using such compou nds for the treatment of HCV or other viral infections.